Polypipe has expounded a consistent strategy since its return to the market in April 2014. The latest set of results further demonstrates that its above market growth focus is delivering good year-on-year profit progress while at the same time occupying strong positions in sectors exhibiting favourable long-term trends. Following recent share price rises, the FY17 P/E rating has risen to 14.7x and we expect Polypipe to sustain a premium rating.

13 Apr 2017
Delivering in line with strategy

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Delivering in line with strategy
Genuit Group PLC (GEN:LON) | 379 24.6 1.7% | Mkt Cap: 944.4m
- Published:
13 Apr 2017 -
Author:
Toby Thorrington -
Pages:
5 -
Polypipe has expounded a consistent strategy since its return to the market in April 2014. The latest set of results further demonstrates that its above market growth focus is delivering good year-on-year profit progress while at the same time occupying strong positions in sectors exhibiting favourable long-term trends. Following recent share price rises, the FY17 P/E rating has risen to 14.7x and we expect Polypipe to sustain a premium rating.